CS204999B2 - Method of producing new banzimidazole derivatives - Google Patents
Method of producing new banzimidazole derivatives Download PDFInfo
- Publication number
- CS204999B2 CS204999B2 CS752989A CS640677A CS204999B2 CS 204999 B2 CS204999 B2 CS 204999B2 CS 752989 A CS752989 A CS 752989A CS 640677 A CS640677 A CS 640677A CS 204999 B2 CS204999 B2 CS 204999B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- salts
- chloroform
- stirred
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- 150000003839 salts Chemical class 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 2
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- 239000013078 crystal Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 7
- -1 3,4-Dichlorophenylcarbamoyl Chemical group 0.000 description 7
- 150000001556 benzimidazoles Chemical class 0.000 description 6
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- HHIRBXHEYVDUAM-UHFFFAOYSA-N 1-chloro-3-isocyanatobenzene Chemical compound ClC1=CC=CC(N=C=O)=C1 HHIRBXHEYVDUAM-UHFFFAOYSA-N 0.000 description 1
- OQURWGJAWSLGQG-UHFFFAOYSA-N 1-isocyanatopropane Chemical compound CCCN=C=O OQURWGJAWSLGQG-UHFFFAOYSA-N 0.000 description 1
- MFUVCHZWGSJKEQ-UHFFFAOYSA-N 3,4-dichlorphenylisocyanate Chemical compound ClC1=CC=C(N=C=O)C=C1Cl MFUVCHZWGSJKEQ-UHFFFAOYSA-N 0.000 description 1
- YUDRVAHLXDBKSR-UHFFFAOYSA-N [CH]1CCCCC1 Chemical compound [CH]1CCCCC1 YUDRVAHLXDBKSR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Předmětem vynálezu je způsob výroby nových benzinu dazolových derivátů a je jich solí.SUMMARY OF THE INVENTION The present invention provides a process for the preparation of novel gasoline dazole derivatives and salts thereof.
Nové benzimidazolové deriváty jsou sloučeniny obecného vzorce IThe novel benzimidazole derivatives are compounds of formula I
(I) a jejich soli, kde(I) and salts thereof, wherein
R je Ci až Co alkylová skupina nebo Cs až Ce cykloalkylová skupina nebo fenylová skupina, popřípadě substituovaná jedním nebo dvěma atomy halogenu,R is a C 1 -C 6 alkyl group or a C 5 -C 6 cycloalkyl group or a phenyl group optionally substituted by one or two halogen atoms,
Pod pojmem alkylová skupina s 1 až 6 atomy uhlíku se rozumějí alifatické skupiny a rovným nebo rozvětveným řetězcem, například methylová, ethylová, n-propylová, isobutylová atd. Pojem cykloalkylová skupina se 3 až 6 atomy uhlíku může znamenat s výhodou cyklopropylový, cyklobutylový, cyklopentylový a cyklohexylový zbytek.The term C 1 -C 6 alkyl refers to aliphatic groups with straight or branched chain, for example methyl, ethyl, n-propyl, isobutyl, etc. The term C 3 -C 6 cycloalkyl may be preferably cyclopropyl, cyclobutyl, cyclopentyl and a cyclohexyl radical.
Solí sloučeniny obecného vzorce I se mají tvořit s anorganickými nebo organickými kyselinami, například kyselinou chlorovodíkovou, bromovodíkovou, sírovou, octovou, mravenčí, mléčnou, vinnou atd. Soli, které se mají používat v lékařství, Sě máji tvořit s farmaceuticky nezávadnými kyselinami.The salts of the compound of formula (I) are to be formed with inorganic or organic acids, for example hydrochloric, hydrobromic, sulfuric, acetic, formic, lactic, tartaric, etc. Salts to be used in medicine should be formed with pharmaceutically acceptable acids.
Zejména výhodné deriváty obecného vzorce I jsou následující sloučeniny:Particularly preferred derivatives of formula I are the following compounds:
1- [' (3,4-dichIorf enyíkarbamoyl) -2- (5‘-nitrof uryl-2‘-karbonýlamino ] behžimidázbly, l-cyklohexylkarbamoyl-2- (5‘-nitrof uryl-2‘-kar bony lamino ] benzimidazoly,1- ['(3,4-Dichlorophenylcarbamoyl) -2- (5'-nitrophuryl-2'-carbonylamino] behimidimidyl, 1-cyclohexylcarbamoyl-2- (5'-nitrophuryl-2'-carbonylamino) benzimidazoles ,
1-n-butylkarbamoy 1-2-{5‘-nitrof uryl-2-kar bonylamino) benzimidazoly,1-n-butylcarbamoy 1-2- (5‘-nitrophenyl-2-carbonylamino) benzimidazoles,
1-f enylkarbamoyl-2- (5‘-nitrofuryl-2‘-karbonylamino) benzimidazoly, l-propylkarbamoyl-2- (5‘-nitrof uryi-2‘-karbonylamino) benzimidazoly,1-Phenylcarbamoyl-2- (5'-nitropuryl-2'-carbonylamino) benzimidazoles, 1-propylcarbamoyl-2- (5'-nitrophuryl-2'-carbonylamino) benzimidazoles,
1-1 (3‘-chlorfeny lkarbamoyl)-2- ] -5“-nitrofttryl‘-2“-kátbúňytominoben2fimidazoly, l-methylkarbamoyl-2- (5‘-nitrof uryl-2‘-karbonylainino)benztmidazoly.1-1 (3‘-Chlorophenylcarbamoyl) -2-] -5'-nitrophthyl-2'-cellobonominominoben 2 -imidazoles, 1-methylcarbamoyl-2- (5‘-nitrophuryl-2‘-carbonylainino) benzimidazoles.
Podle vynálezu se sloučeniny obecného vzorce IAccording to the invention, the compounds of the formula I are used
(I) a jejich soli, kde(I) and salts thereof, wherein
R je Ci až C6 alkylová skupina nebo Cs až C6 cykloalkylová skupina nebo fenylová skupina, popřípadě substituovaná jedním nebo dvěma atomy halogenu, vyrobí tak, že se sloučenina vzorce IIR is a C 1 -C 6 alkyl group or a C 5 -C 6 cycloalkyl group or a phenyl group optionally substituted by one or two halogen atoms, prepared by producing a compound of formula II
nechá reagovat s isokyanátem obecného vzorce III,reacted with an isocyanate of formula III,
R_N=C=O (ΙΠ) kdeR_N = C = O (ΙΠ) where
R má stejný význam jako shora, v přítomnosti rozpouštědla, například tetrachlormetanu, a poté se získaná sloučenina obecného vzorce I popřípadě převede na své soli·R has the same meaning as above, in the presence of a solvent such as carbon tetrachloride, and then the compound of formula I obtained is optionally converted into its salts.
Sloučeniny obecného vzorce I se mohou převádět na své soli obecně známými postupy reakcí sloučeniny obecného vzorce I s přibližně ekvimolárním množstvím kyseliny v přítomnosti organického rozpouštědla.Compounds of formula I may be converted into their salts by generally known methods by reacting a compound of formula I with an approximately equimolar amount of acid in the presence of an organic solvent.
Sloučeniny obecného vzorce I a jejich soli jtsou vynikajícími fungicidy a mohou se používat jak v humánní, tak í veterinární medicíně a také v zemědělství.The compounds of formula I and their salts are excellent fungicides and can be used in both human and veterinary medicine as well as in agriculture.
Další podrobnosti lze seznat z dále uvedených příkladů, aniž se vynález omezuje na tyto příklady.Further details can be learned from the examples below without limiting the invention to these examples.
PřikladlHe did
6,8 g (25 milimolů) amidu N-(2‘-benzimidazolyl) -5-nitrof urankarboxylové kyseliny se míchá se 60 ml chloroformu, potom se k roztoku přidá 4,8 g (25 milimolů) 3,4-dichlorfenylisokyanátu. Reakční směs se míchá při teplotě místnosti 6 hodin, potom se nechá stát přes noc a vysrážené krystaly se odfiltrují. l-(3,4-Dichlorfenylkarbamoyl )-2-( 5‘-nitr ofuryl-2-karbony lamino) benzimidazol se získá ve formě žlutých krystalů, tajících při 235 až 237 °C. Příklad 26.8 g (25 millimoles) of N- (2 benz-benzimidazolyl) -5-nitroph uranecarboxylic acid amide are stirred with 60 ml of chloroform, then 4.8 g (25 millimoles) of 3,4-dichlorophenyl isocyanate are added to the solution. The reaction mixture was stirred at room temperature for 6 hours, then allowed to stand overnight and the precipitated crystals were filtered off. 1- (3,4-Dichlorophenylcarbamoyl) -2- (5‘-nitropyuryl-2-carbonylamino) benzimidazole was obtained as yellow crystals, melting at 235-237 ° C. Example 2
6,8 g (25 milimolů) amidu N-(2‘-benzimidazolyl) -5-nitrofurankarboxylové kyseliny se míchá v 60 ml chloroformu, potom se přidá 3,2 g (25 milimolů) cyklohexylisokyanátu. Reakční směs se míchá 6 hodin, potom se nechá jednu hodinu stát, vysrážený produkt se odfiltruje a promyje malým množstvím chloroformu. Získá se 8,0 g 1-cyklohexylkarbamoyl-2- (5‘-nitrofuryl-2‘-karbonylamino) benzimidazolu. T. t.: 208 až 213 °C (žluté krystaly).6.8 g (25 mmol) of N- (2 (-benzimidazolyl) -5-nitrofurancarboxylic acid amide are stirred in 60 ml of chloroform, then 3.2 g (25 mmol) of cyclohexyl isocyanate are added. The reaction mixture is stirred for 6 hours, then left to stand for one hour, the precipitated product is filtered off and washed with a small amount of chloroform. 8.0 g of 1-cyclohexylcarbamoyl-2- (5‘-nitrofuryl-2‘-carbonylamino) benzimidazole are obtained. Mp: 208-213 ° C (yellow crystals).
Příklad 3Example 3
6,8 g (25 milimolů) amidu N-(2‘-benzimidazolyl)-5-nitrofurankarboxylové kyseliny se míchá v 60 ml chloroformu, potom se k roztoku přidá 2,48 g (25 milimolů) butylisokyanátu a reakční směs se míchá 6 hodin. Reakční směs se nechá stát přes noc, vysrážený produkt se odfiltruje a promyje chloroformem. Získá se 8,05 g 1-n-butylkarbamoyl-2- (5-nitrofuryl-2‘-karbonylamino) benzimidazolu, Bod tání žlutých krystalů činí 253 až 259 °C.6.8 g (25 mmol) of N- (2'-benzimidazolyl) -5-nitrofurancarboxylic acid amide was stirred in 60 ml of chloroform, then 2.48 g (25 mmol) of butyl isocyanate was added to the solution and the reaction mixture was stirred for 6 hours . The reaction mixture was allowed to stand overnight, the precipitated product was filtered off and washed with chloroform. 8.05 g of 1-n-butylcarbamoyl-2- (5-nitrofuryl-2'-carbonylamino) benzimidazole are obtained. The melting point of the yellow crystals is 253-259 ° C.
Příklad 4Example 4
6,8 g (25 ipilimolů] amidů N-2‘-benzimldazolyl) -5-nitrofurankarboxylové kyseliny se suspenduje v 60 ml chloroformu, potom se přidají 3,0 g (25 milimolů) fenyUsokyanátu. Reakční směs se míchá 6 hodin při teplotě místnosti, potom se vysrážený produkt odfiltruje a promyje malým množstvím chloroformu. Získá se 8,6 g 1-fenylkarbamoyl-2- (5‘-nitrofuryl-2‘-karbonylamino) benzimidazolu (B. t. 253 až 255 °C) (žluté krystaly).6.8 g (25 µmol) of N-2‘-benzimldazolyl) -5-nitrofurancarboxylic acid amides are suspended in 60 ml of chloroform, then 3.0 g (25 mmoles) of phenylene isocyanate are added. The reaction mixture was stirred at room temperature for 6 hours, then the precipitated product was filtered off and washed with a small amount of chloroform. 8.6 g of 1-phenylcarbamoyl-2- (5'-nitrofuryl-2'-carbonylamino) benzimidazole (m.p. 253 DEG-255 DEG C.) are obtained (yellow crystals).
Příklad 5Example 5
6,8 g (25 milimolů) amidu N-(2‘-benzimidazolyl)-5-nltrofurankarboxyldvé kyseliny se míchá v 60 ml chloroformu, potom se přidá6.8 g (25 millimoles) of N- (2 benz-benzimidazolyl) -5-nitro-furanecarboxylic acid amide were stirred in 60 ml of chloroform, then added.
2,15 g (25 milimolů) propylisokyanátu. Reakční směs se míchá při teplotě místnosti 6 hodin, potom se zfiltruje a promyje malým množstvím chloroformu. Získá se 8,3 g l-propylkarbamoyl-2- (5‘-nitrof uryl-2‘-karbony lamino)benzimidazolu. B. t.: 260 až 262°C (žluté krystaly).2.15 g (25 millimoles) of propyl isocyanate. The reaction mixture was stirred at room temperature for 6 hours, then filtered and washed with a small amount of chloroform. 8.3 g of 1-propylcarbamoyl-2- (5 ' -nitrophuryl-2 ' -carbonylamino) benzimidazole are obtained. Mp: 260-262 ° C (yellow crystals).
Příklad 6Example 6
6,8 g (25 milimolů) amidu N-(2‘-benzimidazolyl)-5-nitrofurankarboxylové kyseliny se míchá v 60 ml chloroformu, potom se při204999 dá 3,8 g (25 milimolů) 3-chlorfenylísokyanátu. (Reakční směs se míchá 6 hodin při teplotě místnosti, zfiltruje a promyje malým množstvím chloroformu. Získá se 9,9 g l-(3-chlorfenylkarbamoyl) -2- (5“-nitr of uryl-2“-karbony lamino jbenzimidazolu. Bod tání žlutých krystalů činí 259 až 260 °C.6.8 g (25 mmol) of N- (2 (-benzimidazolyl) -5-nitrofurancarboxylic acid amide are stirred in 60 ml of chloroform, then 3.8 g (25 mmol) of 3-chlorophenylisocyanate are added at 20.4999. (The reaction mixture was stirred at room temperature for 6 hours, filtered and washed with a small amount of chloroform to give 9.9 g of 1- (3-chlorophenylcarbamoyl) -2- (5'-nitruryl-2'-carbonylamino) benzimidazole. melting of the yellow crystals is 259-260 ° C.
Příklad 7Example 7
6,8 g (25 milimolů] amidu N-(2‘-benzimidazolylj-5-nitrofurankarboxylové kyseliny se míchá se 60 ml chloroformu, potom se přidá 1,5 g (25 milimolů] methylisokyanfitu. Reakční směs se míchá při teplotě místnosti 6 hodin, potom se vysrážený produkt zfiltruje a promyje malým množstvím chloroformu. Získá se 7,6 g 1-methylkarbamoyl-2- (5‘-nitrof uryl-2‘-karbonylamino j benzimidazolu. B. t.: 267 až 269 °C (žluté krystaly).6.8 g (25 mmol) of N- (2'-benzimidazolyl) -5-nitrofurancarboxylic acid amide was stirred with 60 ml of chloroform, then 1.5 g (25 mmol) of methyl isocyanite were added and the reaction mixture was stirred at room temperature for 6 hours , then the precipitated product is filtered and washed with a small amount of chloroform to give 7.6 g of 1-methylcarbamoyl-2- (5'-nitrophuryl-2'-carbonylamino) benzimidazole, mp 267-269 ° C (yellow) crystals).
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU74CI00001473A HU171244B (en) | 1974-05-02 | 1974-05-02 | Process for preparing new derivatives of the benzimidazole and herbicides containing such compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS204999B2 true CS204999B2 (en) | 1981-04-30 |
Family
ID=10994517
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS752989A CS205000B2 (en) | 1974-05-02 | 1975-04-29 | Fungicide means |
| CS752989A CS204999B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new banzimidazole derivatives |
| CS752989A CS204998B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new benzimidazole derivatives |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS752989A CS205000B2 (en) | 1974-05-02 | 1975-04-29 | Fungicide means |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS752989A CS204998B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new benzimidazole derivatives |
Country Status (11)
| Country | Link |
|---|---|
| CS (3) | CS205000B2 (en) |
| DD (1) | DD120194A1 (en) |
| DK (1) | DK190675A (en) |
| FI (1) | FI751289A7 (en) |
| HU (1) | HU171244B (en) |
| IL (1) | IL47185A0 (en) |
| IN (1) | IN141703B (en) |
| PL (3) | PL106064B1 (en) |
| SE (1) | SE7505025L (en) |
| SU (2) | SU584769A3 (en) |
| YU (2) | YU109175A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12014500326B1 (en) * | 2011-08-18 | 2018-01-10 | Nippon Shinyaku Co Ltd | Heterocyclic derivative and pharmaceutical drug |
-
1974
- 1974-05-02 HU HU74CI00001473A patent/HU171244B/en unknown
-
1975
- 1975-04-26 IN IN847/CAL/75A patent/IN141703B/en unknown
- 1975-04-28 IL IL47185A patent/IL47185A0/en unknown
- 1975-04-29 CS CS752989A patent/CS205000B2/en unknown
- 1975-04-29 DD DD185755A patent/DD120194A1/xx unknown
- 1975-04-29 YU YU01091/75A patent/YU109175A/en unknown
- 1975-04-29 CS CS752989A patent/CS204999B2/en unknown
- 1975-04-29 SE SE7505025A patent/SE7505025L/en unknown
- 1975-04-29 CS CS752989A patent/CS204998B2/en unknown
- 1975-04-29 FI FI751289A patent/FI751289A7/fi not_active Application Discontinuation
- 1975-04-30 SU SU7502131951A patent/SU584769A3/en active
- 1975-05-01 DK DK190675A patent/DK190675A/en not_active Application Discontinuation
- 1975-05-02 PL PL1975193637A patent/PL106064B1/en unknown
- 1975-05-02 PL PL1975180100A patent/PL99545B1/en unknown
- 1975-05-02 PL PL1975193636A patent/PL102170B1/en unknown
-
1976
- 1976-04-15 SU SU762348905A patent/SU626694A3/en active
-
1981
- 1981-04-27 YU YU01081/81A patent/YU108181A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU171244B (en) | 1977-12-28 |
| SU626694A3 (en) | 1978-09-30 |
| IN141703B (en) | 1977-04-09 |
| YU109175A (en) | 1982-02-28 |
| FI751289A7 (en) | 1975-11-03 |
| YU108181A (en) | 1982-02-28 |
| PL99545B1 (en) | 1978-07-31 |
| SU584769A3 (en) | 1977-12-15 |
| SE7505025L (en) | 1975-11-03 |
| PL193637A1 (en) | 1978-02-27 |
| CS205000B2 (en) | 1981-04-30 |
| PL102170B1 (en) | 1979-03-31 |
| CS204998B2 (en) | 1981-04-30 |
| PL193636A1 (en) | 1978-02-13 |
| PL106064B1 (en) | 1979-11-30 |
| IL47185A0 (en) | 1975-06-25 |
| DD120194A1 (en) | 1976-06-05 |
| DK190675A (en) | 1975-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wright | The chemistry of the benzimidazoles. | |
| US4584383A (en) | Substituted 2-mercapto-imidazoles and their preparation | |
| CA1120471A (en) | Adamantylmethyl hydrazines, their preparation and pharmaceutical composition containing them | |
| US3812145A (en) | Process for the preparation of pyrazolone derivatives | |
| US4018790A (en) | Substituted 1-sulfonylbenzimidazoles | |
| CH647237A5 (en) | 5-THIOBENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF IN ANTHELMINTIC PREPARATIONS. | |
| CS204999B2 (en) | Method of producing new banzimidazole derivatives | |
| US3234217A (en) | Pyrazole carboxylic acid hydrazides | |
| Heymann et al. | Derivatives of p, p'-Diaminodiphenyl Sulfone1a | |
| US3900476A (en) | 2(2'-pyrimidylamino)quinazolines and their preparation | |
| US3455948A (en) | 2-aminobenzimidazole and a process for preparing 2-aminobenzimidazoles | |
| US3501492A (en) | Preparation of benzimidazoles | |
| HU188074B (en) | Process for the preparation of cimetidin | |
| US4316021A (en) | Substituted 1-sulfonylbenzimidazoles | |
| DK164052B (en) | SUBSTITUTED AZABICYCLOHEPTANES AND ACID ADDITION SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, PROCEDURES FOR PREPARING THEM AND USING THESE COMPOUNDS FOR PREPARATION | |
| CA1050552A (en) | Benzimidazole derivatives | |
| SU740780A1 (en) | Method of preparing derivatives of 2-/2-(5"-nitrofuryl-2")-vinyl- or butadienyl/-quinoline-4-carboxylic acids | |
| CA1087195A (en) | Benzimidazole derivatives | |
| CA1248960A (en) | Substituted 2-mercapto-imidazoles | |
| US2728765A (en) | Penicillin salts of bis-aralkylalkenylenediamines | |
| Ebetino et al. | Chemotherapeutic Nitrofurans. IX. 1 2-[1-Acyl-2-(5-nitrofurfurylidene) hydrazino] acetamides | |
| US3914242A (en) | 3-Imino-1,2-benzisothiazolines | |
| US3324127A (en) | Hydrouracil process | |
| US3324117A (en) | Carboxylic acid piperazides and process for their manufacture | |
| US3453286A (en) | Process for preparing cycloheptimidazolinium halides |